(Y63.4) Failure in dosage in electroshock or insulin-shock therapy

More details coming soon

Icon
19 147 in individuals diagnosis failure in dosage in electroshock or insulin-shock therapy confirmed
Icon
4 061 deaths with diagnosis failure in dosage in electroshock or insulin-shock therapy
Icon
21% mortality rate associated with the disease failure in dosage in electroshock or insulin-shock therapy

Diagnosis failure in dosage in electroshock or insulin-shock therapy is diagnosed Women are 1.16% more likely than Men

9 462

Men receive the diagnosis failure in dosage in electroshock or insulin-shock therapy

2 677 (28.3 %)

Died from this diagnosis.

100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
9 685

Women receive the diagnosis failure in dosage in electroshock or insulin-shock therapy

1 384 (14.3 %)

Died from this diagnosis.

Risk Group for the Disease failure in dosage in electroshock or insulin-shock therapy - Men aged 50-54 and Women aged 45-49

Icon
In Men diagnosis is most often set at age 25-29, 50-59, 65-79, 85-89
Icon
Less common in men the disease occurs at Age 0-24, 30-49, 60-64, 80-84, 90-95+Less common in women the disease occurs at Age 0-44, 55-64, 75-79, 85-95+
Icon
In Women diagnosis is most often set at age 45-54, 65-74, 80-84

Disease Features failure in dosage in electroshock or insulin-shock therapy

Icon
Absence or low individual and public risk
Icon

Failure in dosage in electroshock or insulin-shock therapy - what does this mean

Failure in dosage in electroshock or insulin-shock therapy occurs when the amount of electricity or insulin administered is too high or too low, resulting in an inadequate response to the treatment or an adverse reaction. if the dosage is too high, the patient may experience seizures, confusion, or memory loss; if the dosage is too low, the patient may not experience the desired therapeutic effects.

What happens during the disease - failure in dosage in electroshock or insulin-shock therapy

Failure in dosage in electroshock or insulin-shock therapy can lead to an inadequate response to treatment, as well as an increased risk of adverse side effects. this is due to the fact that the amount of electrical current or insulin administered is not enough to produce the desired effect, resulting in an inadequate response to treatment and potentially causing further complications.

Clinical Pattern

More details coming soon

How does a doctor diagnose

  • Take a detailed medical history of the patient.
  • Order laboratory tests to determine levels of electrolytes, glucose, and other metabolic parameters.
  • Perform a physical examination.
  • Conduct an electrocardiogram (ECG) to check for any heart abnormalities.
  • Conduct an electroencephalogram (EEG) to check for any brain abnormalities.
  • Order an imaging study such as a CT scan or MRI to check for any structural abnormalities.
  • Perform a psychological assessment to check for any mental health disorders.
  • Conduct a neuropsychological evaluation to assess cognitive functioning.
  • Perform a drug screening to check for any medications or drugs that may be causing the problem.
Additional measures:
  • Monitor the patient’s response to treatment.
  • Assess the patient’s compliance with the therapy.
  • Conduct a post-treatment evaluation to assess the effectiveness of the therapy.

Treatment and Medical Assistance

Main Goal: Treat Failure in Dosage in Electroshock or Insulin-Shock Therapy
  • Evaluate patient's medical history for risk factors
  • Monitor patient's vital signs during therapy
  • Administer appropriate dosage of medication
  • Monitor patient's response to therapy
  • Adjust dosage as needed
  • Provide patient with education on the therapy
  • Provide patient with a support system
  • Provide patient with follow-up care
Icon
15 Days of Hospitalization Required
Icon
Average Time for Outpatient Care Not Established

Failure in dosage in electroshock or insulin-shock therapy - Prevention

The best way to prevent failure in dosage in electroshock or insulin-shock therapy is to ensure that the patient is closely monitored during the procedure, and that the dosage is carefully calculated and administered according to the patient's individual needs. additionally, it is important to adhere to all safety protocols and guidelines, and to ensure that the patient is properly informed of the risks and benefits associated with the procedure.